(71)
P.A.
CONFIDENTIAL
НК 16G
1
GPS 482
CONFIDENTIAL
DESKEY 243902Z
FM HONG KONG 250750Z JUL 80
TO IMMEDIATE FCO
TELEGRM NUMBER 936 OF 25 JULY
INFO IMMEDIATE PEKING
INFO ROUTINE HONG KONG GOVT OFFICE LONDON
RECEIVED IN REGISTRY NO. 51
2 8 JUL 1980
DESK OFFICER INDEX
No.
PA
か
REGISTRY
Action
See unn 166
(24) +25 Ex
166/1
GR
se
MYTELNO 855: GUANGDONG NUCLEAR PROJECT. SIR LAWRENCE KADOORIE, CHAIRMAN OF CHINA LIGHT AND POWER { CLP) WILL BE IN LONDON NEXT WEEK AND WILL BE SEEING THE PRIME MINISTER, LORD PRIVY SEAL AND SIR KEITH JOSEPH. HE WILL BE TALKING TO ALL THREE ABOUT CLP'S DISCUSSIONS WITH GUANGDONG ON BUILDING A NUCLEAR POWER STATION THERE WITH AT LEAST 60 PER CENT OF THE OUTPUT GOING
TO HONG KONG.
2. YOU WILL KNOW THE CURRENT STATE OF NEGOTIATIONS BETWEEN CLP AND GUANGDONG FROM BTC TELEGRAMS AND FROM DR MARSHALL, WHO HAS
NOW RETURNED TO THE UK.
3. THERE ARE TWO ASPECTS OF PARTICULAR RELEVANCE TO KADOORIE'S
VISIT:
(A) COMMERCIAL OPPORTUNITIES FOR THE UK: AND
(B) THE POLITICAL IMPLICATIONS. ON (A) THE DISCUSSIONS SO FAR HAVE BEEN GOING IN THE FIGHT DIRECTION. BUT COMPETITIVE PRICES AND ADEQUATE FINANCIAL ARRANGEMENTS ARE CLEARLY GOING TO BE CRUCIAL IF THE UK IS TO GET A GOOD SHARE.
4. ON (B) THERE WOULD BE SUBSTANTIAL POLITICAL BENEFIT FROM A MAJOR JOINT VENTURE OF THIS SORT. IT WOULD NOT ONLY DEMONSTRATE SUCCESSFUL CO-OPERATION BUT ALSO REQUIRE AMORTISATION OF LOANS OVER A LONG PERIOD WITH FOREIGN EXCHANGE EARNED FROM SALES TO HONG KONG. TO ACHIEVE THIS POLITICAL BENEFIT A LONG TERM FINANCIAL PACKAGE WILL BE CRUCIAL (SEE MYTELNO 255, PARA 2- NOT TO PEKING).
5. KADOORIE WILL PRESS THE POLITICAL SIGNIFICANCE OF THE PROJECT
. HE WILL ALMOST CERTAINLY ASK FOR DIRECT HMG PARTICIPATION IN THE SEPARATE COMPANY HE PLANS TO ESTABLISH, TOGETHER WITH THE CHINESE TO OWN AND MANAGE THE NUCLEAR POWER STATION. I ASSUME THAT HMG WILL WISH TO RESERVE THEIR POSITION ON SUCH A PROPOSAL UNTIL THE NEGOTIATIONS ARE FURTHER ADVANCED. BUT I HOPE THAT MINISTERS WILL
CONFIDENTIAL
/BE ABLE
No comments yet.
Private notes are available after approval.